Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares A Study of NST-628 in Recurrent Grade 4 Glioma, Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects, MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma, A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors and the tag umbrella.
Shares DROSHA, MUTYH, Tozuleristide, DICER1 and the tag umbrella.
Shares Pediatric Brain Tumor Foundation, Dragon Master Initiative, Sam Day Foundation, The Cure Starts Now and the tag umbrella.
Shares A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations, IELSG32, MATRix/IELSG43, Primary CNS lymphoma and the tag umbrella.
Shares DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas, Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas, Combination Therapy for the Treatment of Diffuse Midline Gliomas, Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects.
Shares Tovorafenib, Vorasidenib, Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, Dabrafenib.
Shares Proliferation-invasion (reaction-diffusion) models of glioma, Radiation necrosis (brain), Laser interstitial thermal therapy systems (NeuroBlate, Visualase), Intraoperative MRI and CT.
Shares EORTC 26951, RTOG 9402, ACNS0121, ACNS1422.
The same record for scripts and assistants; checked 2026-09-04. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.